Packages of Care for Dementia in Low- and Middle-Income Countries
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
This is the fifth in a series of articles highlighting the delivery of ''packages of care'' for mental health disorders in low-and middleincome countries.Packages of care are combinations of treatments aimed at improving the recognition and management of conditions to achieve optimal outcomes. Detection and Diagnosis of DementiaMany cases of dementia, particularly in LMICs, go undetected,in part because of lack of awareness.Awareness of this disorder can be boosted by dissemination of information from governments, health care providers, and media.Help-seeking can be encouraged by improved case-finding.In India and Brazil, for example, community
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Cholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671 · cited 1×
“Use of these drugs in dementia is associated with an increased risk of death and cerebrovascular adverse events [62,64–68].”
Background(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., Luchsinger, J. A., Ogunniyi, A., Perry, E. K., Potocnik, F., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70169-8 · Cited by 1,233 · cited 4×
“The evidence base for ChEIs from LMICs is limited to one small RCT of donepezil in Brazil [52] and open-label trials of galantamine in Brazil [53] and China [54].”
BackgroundInfluentialSelf-citationDonepezil for dementia due to Alzheimer’s disease.
Birks, J. S., & Harvey, R. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190.pub3 · Cited by 1,200
McShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155
Meta‐Analysis of Psychosocial Interventions for Caregivers of People with Dementia
Brodaty, H., Green, A., & Koschera, A. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1600-0579.2003.00210.x · Cited by 952 · cited 2×
“subjective wellbeing, and psychological morbidity Carer interventions Meta-analyses of controlled studies (including nonrandomised trials) of carer interventions in general [ 86 ] and the specific effects of psychoeducational, interventions, CBT, counselling, and respite care [84]; Meta-analysis of RCTs of respite car…”
BackgroundSchneider, L. S., Dagerman, K., & Insel, P. S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000200589.01396.6d · Cited by 903
Pinquart, M., & Sorensen, S. (2006) · International Psychogeriatrics · doi:10.1017/s1041610206003462 · Cited by 827 · cited 10×
“Carer support increased carer wellbeing but no other outcomes [84].”
BackgroundMethodInfluentialAntipsychotic Drug Use and Mortality in Older Adults with Dementia
Gill, S. S., Bronskill, S. E., Normand, S.-L. T., Anderson, G. M., Sykora, K., Lam, K., Bell, C. M., Lee, P. E., Fischer, H. D., Herrmann, N., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-11-200706050-00006 · Cited by 624
Dementia diagnosis in developing countries: a cross-cultural validation study
Prince, M., Acosta, D., Chiu, H., Scazufca, M., & Varghese, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12772-9 · Cited by 594
Self-citationClare, L., & Woods, B. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003260 · Cited by 576 · cited 3×
“Cognitive rehabilitation, an individualised therapy designed to enhance residual cognitive skills and cope with deficits, showed promise in uncontrolled case series undertaken in HICs [46].”
BackgroundMethodRivastigmine for Alzheimer’s disease.
Birks, J. S., Chong, L.-Y., & Grimley Evans, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001191.pub4 · Cited by 534
Kavirajan, H., & Schneider, L. S. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70195-3 · Cited by 497
Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia
Tariot, P. N., Erb, R., Podgorski, C. A., Cox, C., Patel, S., Jakimovich, L., & Irvine, C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.54 · Cited by 422 · cited 2×
“Anticonvulsants Two small RCTs of carbamezepine [76,77] —”
BackgroundManagement of agitation and aggression associated with Alzheimer disease
Ballard, C. G., Gauthier, S., Cummings, J. L., Brodaty, H., Grossberg, G. T., Robert, P., & Lyketsos, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.39 · Cited by 404 · cited 1×
“To avoid missing underlying conditions, a physical assessment is recommended before specific treatments for BPSD are initiated [29],”
BackgroundLyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398 · cited 1×
“Only two small trials were included in this meta-analysis, one of which suggested a benefit of sertraline for some depression outcomes [71].”
BackgroundDementia care: mental health effects, intervention strategies, and clinical implications
Sörensen, S., Duberstein, P., Gill, D., & Pinquart, M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70599-3 · Cited by 396 · cited 2×
“A large literature attests to the benefits of carer interventions in dementia [83].”
BackgroundPollock, B. G., Mulsant, B. H., Rosen, J., Sweet, R. A., Mazumdar, S., Bharucha, A., Marin, R., Jacob, N. J., Huber, K. A., Kastango, K. B., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.460 · Cited by 327
Donepezil for the Treatment of Agitation in Alzheimer's Disease
Howard, R. J., Juszczak, E., Ballard, C. G., Bentham, P., Brown, R. G., Bullock, R., Burns, A. S., Holmes, C., Jacoby, R., Johnson, T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066583 · Cited by 327 · cited 1×
“Their efficacy for the treatment of disturbed behaviour is not established; manufacturer-sponsored licensing trials [51] and post hoc analyses [58] indicate small improvements that have not been confirmed in independent trials [59] and meta-analyses [56].”
BackgroundNeuroleptic drugs in dementia: benefits and harm
Ballard, C., & Howard, R. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1926 · Cited by 308 · cited 1×
“Meta-analyses of RCTs of haloperidol [60] and atypical antipsychotic drugs for the treatment of agitation [61] and BPSD [62] indicate small treatment effects, most evident for aggression [62,63].”
BackgroundAn estimate of the total worldwide societal costs of dementia in 2005
Wimo, A., Winblad, B., & Jönsson, L. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.02.001 · Cited by 300 · cited 1×
“. Its global cost is estimated to be US$317 billion, 77% of this total arising in HICs where formal sector care costs increase with disease progression, and institutionalization is the main cost driver”
BackgroundCare arrangements for people with dementia in developing countries
(2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1046 · Cited by 274
Self-citationExposure to antipsychotics and risk of stroke: self controlled case series study
Douglas, I. J., & Smeeth, L. (2008) · BMJ · doi:10.1136/bmj.a1227 · Cited by 272
Kales, H. C., Valenstein, M., Kim, H. M., McCarthy, J. F., Ganoczy, D., Cunningham, F., & Blow, F. C. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06101710 · Cited by 258 · cited 1×
“Use of these drugs in dementia is associated with an increased risk of death and cerebrovascular adverse events [62,64–68].”
BackgroundWilcock, G. K., Ballard, C. G., Cooper, J. A., & Loft, H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0302 · Cited by 253
Spijker, A., Vernooij‐Dassen, M., Vasse, E., Adang, E., Wollersheim, H., Grol, R., & Verhey, F. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01705.x · Cited by 223 · cited 2×
“A systematic review of ten RCTs indicated a 40% reduction in the pooled odds of institutionalisation [88]; the effective interventions were structured, intensive, and multicomponent, offering a choice of services and supports [84,88].”
BackgroundMethodAntidepressants for treating depression in dementia
Bains, J., Birks, J., & Dening, T. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944 · Cited by 214
Haloperidol for agitation in dementia
Lonergan, E., Luxenberg, J., Colford, J. M., & Birks, J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002852 · Cited by 212
Packages of care for depression in low- and middle-income countries
Patel, V., Simon, G., Chowdhary, N., Kaaya, S., & Araya, R. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000159 · Cited by 202 · cited 1×
“Carer strain, whether or not associated with BPSD, should trigger more intensive intervention that includes psychological assessment and depression treatment for the carer [101], respite, and carer education and training.”
BackgroundCalming Music and Hand Massage With Agitated Elderly
Remington, R. (2002) · Nursing Research · doi:10.1097/00006199-200209000-00008 · Cited by 189
Rait, G., Fletcher, A., Smeeth, L., Brayne, C., Stirling, S., Nunes, M., Breeze, E., Ng, E. S.-W., Bulpitt, C. J., Jones, D., et al. (2005) · Age and Ageing · doi:10.1093/ageing/afi039 · Cited by 180
Olin, J. T., Fox, L. S., Pawluczyk, S., Taggart, N. A., & Schneider, L. S. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00008 · Cited by 163
Cited by
The worldwide economic impact of dementia 2010
Wimo, A., Jönsson, L., Bond, J., Prince, M., Winblad, B., & International, A. D. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.006 · Cited by 1,141
Self-citationScale up of services for mental health in low-income and middle-income countries
Eaton, J., McCay, L., Semrau, M., Chatterjee, S., Baingana, F., Araya, R., Ntulo, C., Thornicroft, G., & Saxena, S. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60891-x · Cited by 698
Gitlin, L. N., Winter, L., Dennis, M. P., Hodgson, N., & Hauck, W. W. (2010) · JAMA · doi:10.1001/jama.2010.1253 · Cited by 367
Prince, M., Brodaty, H., Uwakwe, R., Acosta, D., Ferri, C. P., Guerra, M., Huang, Y., Jacob, K., Llibre Rodriguez, J. J., Salas, A., et al. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2727 · Cited by 119
Self-citationPublic knowledge about dementia in South Korea: a community-based cross-sectional survey
Seo, H.-J., Lee, D. Y., & Sung, M. R. (2015) · International Psychogeriatrics · doi:10.1017/s1041610214001896 · Cited by 49
Metadata
- Authors
- Prince, M. J., Acosta, D., Castro-Costa, E., Jackson, J., & Shaji, K. S.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-11-03
- Volume
- 6
- Issue
- 11
- Pages
- e1000176
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2094126102
- Cited by
- 92
- References
- 34
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.